INCR
Price
$5.16
Change
-$0.08 (-1.53%)
Updated
Sep 11 closing price
Capitalization
78.77M
66 days until earnings call
Intraday BUY SELL Signals
PRFX
Price
$0.86
Change
-$0.07 (-7.53%)
Updated
Sep 11 closing price
Capitalization
3.04M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INCR vs PRFX

INCR vs PRFX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
INCR vs. PRFX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCR is a StrongBuy and PRFX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCR($78.8M) has a higher market cap than PRFX($3.04M). INCR has higher P/E ratio than PRFX: INCR (25.48) vs PRFX (0.02). INCR YTD gains are higher at: 13.407 vs. PRFX (-73.197). PRFX has higher annual earnings (EBITDA): -4.32M vs. INCR (-7.29M). INCR has higher revenues than PRFX: INCR (270M) vs PRFX (31K).
INCRPRFXINCR / PRFX
Capitalization78.8M3.04M2,589%
EBITDA-7.29M-4.32M169%
Gain YTD13.407-73.197-18%
P/E Ratio25.480.02156,781%
Revenue270M31K870,968%
Total CashN/A11.5M-
Total DebtN/A50K-
FUNDAMENTALS RATINGS
INCR vs PRFX: Fundamental Ratings
INCR
PRFX
OUTLOOK RATING
1..100
5787
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4490
P/E GROWTH RATING
1..100
497
SEASONALITY SCORE
1..100
5024

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRFX's Valuation (38) in the null industry is in the same range as INCR (50) in the Servicestothe Health Industry industry. This means that PRFX’s stock grew similarly to INCR’s over the last 12 months.

PRFX's Profit vs Risk Rating (100) in the null industry is in the same range as INCR (100) in the Servicestothe Health Industry industry. This means that PRFX’s stock grew similarly to INCR’s over the last 12 months.

INCR's SMR Rating (94) in the Servicestothe Health Industry industry is in the same range as PRFX (98) in the null industry. This means that INCR’s stock grew similarly to PRFX’s over the last 12 months.

INCR's Price Growth Rating (44) in the Servicestothe Health Industry industry is somewhat better than the same rating for PRFX (90) in the null industry. This means that INCR’s stock grew somewhat faster than PRFX’s over the last 12 months.

INCR's P/E Growth Rating (4) in the Servicestothe Health Industry industry is significantly better than the same rating for PRFX (97) in the null industry. This means that INCR’s stock grew significantly faster than PRFX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INCRPRFX
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
69%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (INCR: $5.16 vs. PRFX: $0.86)
Brand notoriety: INCR and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INCR: 1% vs. PRFX: 53%
Market capitalization -- INCR: $78.77M vs. PRFX: $3.04M
INCR [@Pharmaceuticals: Generic] is valued at $78.77M. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $3.04M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCR’s FA Score shows that 1 FA rating(s) are green while PRFX’s FA Score has 0 green FA rating(s).

  • INCR’s FA Score: 1 green, 4 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, INCR is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCR’s TA Score shows that 4 TA indicator(s) are bullish while PRFX’s TA Score has 4 bullish TA indicator(s).

  • INCR’s TA Score: 4 bullish, 7 bearish.
  • PRFX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PRFX is a better buy in the short-term than INCR.

Price Growth

INCR (@Pharmaceuticals: Generic) experienced а -4.80% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -11.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

Reported Earning Dates

INCR is expected to report earnings on Nov 17, 2026.

PRFX is expected to report earnings on Nov 19, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
INCR
Daily Signal:
Gain/Loss:
PRFX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFVLX27.260.45
+1.68%
Applied Finance Select Investor
AEMRX18.420.15
+0.82%
American Century Emerging Markets R
AATIX18.41N/A
N/A
Ancora/Thelen Small-Mid Cap I
MITHX37.61N/A
N/A
MFS Massachusetts Investors Tr R3
RYINX158.48N/A
N/A
Rydex Internet A

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and SNDL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and SNDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
-1.53%
SNDL - INCR
25%
Poorly correlated
N/A
AKAN - INCR
24%
Poorly correlated
+2.33%
TRLV - INCR
23%
Poorly correlated
-0.09%
CRON - INCR
23%
Poorly correlated
-0.63%
SUPN - INCR
23%
Poorly correlated
-0.12%
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and AMRX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
-7.27%
AMRX - PRFX
24%
Poorly correlated
+0.83%
INCR - PRFX
23%
Poorly correlated
-1.53%
LFCR - PRFX
21%
Poorly correlated
+0.73%
KMDA - PRFX
21%
Poorly correlated
-0.88%
SUPN - PRFX
21%
Poorly correlated
-0.12%
More